lysine has been researched along with mdv 3100 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Broos, W; Knol, R; van der Zant, F; Wondergem, M | 1 |
| Deng, Y; He, X; Hu, T; Huang, H; Kong, W; Liao, Y; Liu, Y; Shao, Z; Sun, W; Xia, X; Yu, C | 1 |
3 other study(ies) available for lysine and mdv 3100
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Increased PSMA Expression in Castration-Resistant Prostate Cancer Metastases 3 Months After Initiation of Enzalutamide Indicated by 18F-DCFPyL PET/CT.
Topics: Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Lymphatic Metastasis; Lysine; Male; Nitriles; Phenylthiohydantoin; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Urea | 2019 |
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
Topics: Animals; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavones; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Proteasome Endopeptidase Complex; Proteolysis; Receptors, Androgen; Ubiquitin Thiolesterase; Ubiquitination | 2021 |